Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Leptin antagonist ameliorates chronic colitis in IL-10⁻/⁻ mice.

Singh UP, Singh NP, Guan H, Busbee B, Price RL, Taub DD, Mishra MK, Fayad R, Nagarkatti M, Nagarkatti PS.

Immunobiology. 2013 Dec;218(12):1439-51. doi: 10.1016/j.imbio.2013.04.020. Epub 2013 May 13.

2.

Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.

Fantini MC, Rizzo A, Fina D, Caruso R, Sarra M, Stolfi C, Becker C, Macdonald TT, Pallone F, Neurath MF, Monteleone G.

Gastroenterology. 2009 Apr;136(4):1308-16, e1-3. doi: 10.1053/j.gastro.2008.12.053. Epub 2008 Dec 27.

PMID:
19192480
3.

Smad7 Knockdown Restores Aryl Hydrocarbon Receptor-mediated Protective Signals in the Gut.

Monteleone I, Marafini I, Zorzi F, Di Fusco D, Dinallo V, Rizzo A, Sileri P, Sica G, Monteleone G.

J Crohns Colitis. 2016 Jun;10(6):670-7. doi: 10.1093/ecco-jcc/jjw030. Epub 2016 Jan 27.

PMID:
26818761
4.

TGF-Beta signaling manipulation as potential therapy for IBD.

Marafini I, Zorzi F, Codazza S, Pallone F, Monteleone G.

Curr Drug Targets. 2013 Nov;14(12):1400-4. Review.

PMID:
23489130
5.

Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases.

Laudisi F, Dinallo V, Di Fusco D, Monteleone G.

Curr Drug Metab. 2016;17(3):303-6. Review.

PMID:
26651974
6.

Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.

Boirivant M, Pallone F, Di Giacinto C, Fina D, Monteleone I, Marinaro M, Caruso R, Colantoni A, Palmieri G, Sanchez M, Strober W, MacDonald TT, Monteleone G.

Gastroenterology. 2006 Dec;131(6):1786-98. Epub 2006 Sep 19.

PMID:
17087939
7.

Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.

Dominitzki S, Fantini MC, Neufert C, Nikolaev A, Galle PR, Scheller J, Monteleone G, Rose-John S, Neurath MF, Becker C.

J Immunol. 2007 Aug 15;179(4):2041-5.

8.

Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.

Singh UP, Singh NP, Singh B, Price RL, Nagarkatti M, Nagarkatti PS.

Toxicol Appl Pharmacol. 2012 Jan 15;258(2):256-67. doi: 10.1016/j.taap.2011.11.005. Epub 2011 Nov 18.

9.

The TGF-β/Smad System in IBD Pathogenesis.

Sedda S, Marafini I, Dinallo V, Di Fusco D, Monteleone G.

Inflamm Bowel Dis. 2015 Dec;21(12):2921-5. doi: 10.1097/MIB.0000000000000542. Review.

PMID:
26230862
10.

Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity.

Han JM, Patterson SJ, Speck M, Ehses JA, Levings MK.

J Immunol. 2014 Jan 15;192(2):623-9. doi: 10.4049/jimmunol.1302181. Epub 2013 Dec 9.

11.

Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine.

Monteleone I, Federici M, Sarra M, Franzè E, Casagrande V, Zorzi F, Cavalera M, Rizzo A, Lauro R, Pallone F, MacDonald TT, Monteleone G.

Gastroenterology. 2012 Nov;143(5):1277-87.e1-4. doi: 10.1053/j.gastro.2012.07.016. Epub 2012 Jul 20.

PMID:
22819866
12.

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT.

J Clin Invest. 2001 Aug;108(4):601-9.

13.

Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice.

Duan L, Chen J, Zhang H, Yang H, Zhu P, Xiong A, Xia Q, Zheng F, Tan Z, Gong F, Fang M.

Mol Med. 2012 Jul 18;18:753-61. doi: 10.2119/molmed.2011.00428.

14.

Growth hormone inhibits signal transducer and activator of transcription 3 activation and reduces disease activity in murine colitis.

Han X, Sosnowska D, Bonkowski EL, Denson LA.

Gastroenterology. 2005 Jul;129(1):185-203.

PMID:
16012947
15.

Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.

Wang H, Dong J, Shi P, Liu J, Zuo L, Li Y, Gong J, Gu L, Zhao J, Zhang L, Zhang W, Zhu W, Li N, Li J.

Immunology. 2015 Feb;144(2):254-62. doi: 10.1111/imm.12366.

16.

The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.

Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, Mizoguchi A, Mizoguchi E, Mudter J, Galle PR, Bhan A, Autschbach F, Sullivan BM, Szabo SJ, Glimcher LH, Blumberg RS.

J Exp Med. 2002 May 6;195(9):1129-43. Erratum in: J Exp Med 2002 Jun 3;195(11):1513.

17.

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Ungaro R, Fukata M, Hsu D, Hernandez Y, Breglio K, Chen A, Xu R, Sotolongo J, Espana C, Zaias J, Elson G, Mayer L, Kosco-Vilbois M, Abreu MT.

Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1167-79. doi: 10.1152/ajpgi.90496.2008. Epub 2009 Apr 9.

18.
19.

FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.

Daniel C, Sartory N, Zahn N, Geisslinger G, Radeke HH, Stein JM.

J Immunol. 2007 Feb 15;178(4):2458-68.

20.

Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation.

Musso A, Dentelli P, Carlino A, Chiusa L, Repici A, Sturm A, Fiocchi C, Rizzetto M, Pegoraro L, Sategna-Guidetti C, Brizzi MF.

Inflamm Bowel Dis. 2005 Feb;11(2):91-8.

PMID:
15677901

Supplemental Content

Support Center